Chief Scientific Officer – New Medicines and Diagnostics Division
Chief Scientific Officer (CSO) role in the Bridging Barriers in Brain Cancer (B3C) program at WEHI, responsible for setting scientific vision and driving delivery of research and translational objectives.
About the Program
B3C aims to transform brain cancer treatment through pioneering medicines that cross the blood‐brain barrier, integrating discovery science, preclinical development, translational strategy and commercial readiness across partner organisations.
About the Position
Reporting to the Centre Director, the CSO will provide strategic oversight across all scientific workstreams, ensure scientific excellence, mentor teams, and guide portfolio prioritisation. Responsibilities include scientific governance, milestone reviews, go/no‐go decision frameworks, and external reputation building with advisory boards, funders, industry partners and the research community.
Selection Criteria
Essential Knowledge and Skills
* PhD or MD/PhD in a relevant scientific discipline.
* Significant leadership experience in drug discovery and development, in neurology, oncology or related areas.
* Experience advancing assets from early discovery through preclinical development.
* Strong understanding of translational science and the pathway to clinical and commercial development.
* Proven ability to lead multidisciplinary teams and manage complex scientific programs.
* Experience within or alongside industry, biotech, or translational environments.
* Excellent communication skills for scientific, governance and industry audiences.
Desirable Knowledge and Skills
* Experience with drug conjugates, biologics, or blood‐brain barrier targeting strategies.
* Prior involvement in biotech formation, licensing or investment processes.
* Experience working across multi‐institutional or international collaborations.
* Familiarity with regulatory considerations for early‐stage therapeutic development.
Terms of Appointment
Position duration: 5 years, full or part‐time (0.6–1.0 FTE). Salary: Research Employee Level D ($173,441–$191,080). Additional benefits include salary packaging options, 12% superannuation with an additional 5% after 6 months through a matching superannuation scheme.
Commitment to Diversity and Inclusion
WEHI values diversity and inclusion, encouraging applications from people with disabilities, culturally and linguistically diverse backgrounds, and diverse genders and sexualities. Aboriginal and Torres Strait Islander peoples are strongly encouraged to apply. The organisation supports gender equality, offers a Diversity and Inclusion Strategy, Gender Action Plan, Reconciliation Action Plan and a WE‐Pride network for LGBTQIA+ staff.
EEO Statement
WEHI is an equal opportunity employer and promotes fair employment practices across all levels of the organisation.
#J-18808-Ljbffr